India's Hetero Drugs to invest in Mexico

Indian pharmaceutical company Hetero Drugs plans to invest $50 million on a new plant in Mexico.

The aim is to continue developing as one of the main producers and providers of pharmaceuticals in the region, said Adrián Ruíz, general director of the firm in Mexico.

Mexico represents a market worth $16 billion a year for the company, Ruíz added.



Source (in Spanish): El Financiero